HealthDay News — Isradipine does not appear to slow progression of disability in patients with de novo Parkinson disease (PD), according to a study presented at the annual meeting of the American Academy of Neurology, held from May 4 to 10 in Philadelphia. Tanya Simuni, MD, from the Northwestern University Feinberg School of Medicine in…
Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes.
Investigators analyzed adherence to monotherapy antiepileptic drug therapy for patients with focal seizures receiving eslicarbazepine acetate vs generic carbamazepine and oxcarbazepine.
A group of investigators discussed clinical trials from multiple neurology society meetings that impact patient care during an AAN 2019 clinical trial plenary session.
Increased waist-to-hip ratio is associated with a higher risk for ischemic stroke and may predict stroke risk more accurately than measures of body mass index.
Researchers sought to determine whether combining memantine with a cholinesterase inhibitor produced early and consistent improvements in cognition for patients with moderate to severe Alzheimer disease.
Older men with type 2 diabetes who received metformin or newer hypoglycemic medication had less cognitive decline compared with those who received sulfonylureas.
Long-term adjunctive treatment with amantadine may enable the levodopa regimen to be optimized in patients with Parkinson experiencing motor complications.
